Search SMTI
Sanara MedTech Inc.
Nasdaq · CIK 714256
Last close34.85
Daily change-0.03 (-0.09%)
10 Years gain+771.25%
Dividends TTM0
Dividend yield0.00%
Fundamental Analysis
SMTI · STANDARD
SIC 3842 · Orthopedic, Prosthetic & Surgical Appliances & Supplies · Fiscal year end 1231
Fundamental
77.6Momentum
75.9Acceleration
85.5Confidence
83.0Annual Revenue16
Quarterly Revenue52
Annual CFO16
Balance SheetAvailable
RankingEligible
Score Breakdown
Growth24.0 / 25
Quality20.9 / 25
Capital Efficiency17.0 / 20
Balance Sheet6.2 / 15
Shareholder Economics5.7 / 10
Forward Indicators0.0 / 5
Signals
Gross margin expansionGross margin improved by 1.6891 percentage points.
Operating leverageOperating margin improved by 5.1703 percentage points.
ROIC expansionROIC improved by 10.6117 percentage points.
Strong operating leverageOperating income is growing faster than revenue while operating margin expands.
Warnings
Low interest coverage · HIGHInterest coverage is 1.3652x.
Key Metrics
Revenue Growth TTM18.02%OK
Revenue CAGR 3Y31.03%OK
Gross Margin92.86%OK
Operating Margin9.12%OK
FCF Marginn/aMISSING
FCF Growthn/aINSUFFICIENT_HISTORY
ROIC15.83%OK
Incremental Operating Margin 3Y38.17%OK
Net Debt / CFOn/aNOT_MEANINGFUL
Diluted Share Growth 1Y1.08%OK
SBC / Revenue4.8%OK
SBC / FCFn/aNOT_MEANINGFUL
Financial History
| Period | Revenue | Gross Profit | Operating Income | CFO | FCF | Gross Margin | Op Margin | FCF Margin | ROIC | Shares |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025 FY Dec 31, 2025 | $103.12M | $95.60M | $7.30M | $6.79M | $2.16M | 92.71% | 7.08% | 2.1% | 12.89% | 8.62M |
| 2025 FY Dec 31, 2024 | $86.67M | $78.53M | $1.26M | -$23,784.00 | -$229,632.00 | 90.61% | 1.45% | -0.26% | 1.92% | 8.48M |
| 2024 FY Dec 31, 2023 | $64.99M | $57.14M | -$4.22M | -$3.25M | -$3.51M | 87.92% | -6.49% | -5.4% | -8.1% | 8.28M |
| 2023 FY Dec 31, 2022 | $45.84M | $39.48M | -$12.52M | -$5.55M | -$5.70M | 86.12% | -27.3% | -12.44% | -44.09% | 7.91M |
| 2022 FY Dec 31, 2021 | $24.14M | $21.83M | -$7.38M | -$4.81M | -$4.99M | 90.43% | -30.55% | -20.65% | -65.91% | n/a |
Formula Trace
| Metric | Value | Formula | Status | Source |
|---|---|---|---|---|
| Revenue TTM | $108.07M | sum latest 4 fiscal quarters Revenue | OK | 0001493152-26-037176, 0001493152-25-021894 |
| Revenue Growth TTM | 18.02% | Revenue_TTM / Revenue_TTM_1Y_ago - 1 | OK | 0001493152-26-037176, 0001493152-25-021894 |
| Revenue CAGR 3Y | 31.03% | (Revenue_current / Revenue_3Y_ago)^(1/3) - 1 | OK | 0001493152-26-012352 |
| Revenue CAGR 5Y | 45.92% | (Revenue_current / Revenue_5Y_ago)^(1/5) - 1 | OK | 0001493152-26-012352 |
| Gross Profit CAGR 3Y | 34.28% | (GrossProfit_current / GrossProfit_3Y_ago)^(1/3) - 1 | OK | 0001493152-26-012352 |
| Operating Income Growth | 172.55% | OperatingIncome_current / OperatingIncome_prior_year - 1 | OK | 0001493152-26-037176, 0001493152-25-021894 |
| FCF Growth | n/a | FCF_current / FCF_prior_year - 1 | INSUFFICIENT_HISTORY | derived |
| Revenue Growth Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Profit Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Operating Income Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| FCF Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Margin | 92.86% | Gross Profit / Revenue | OK | 0001493152-26-037176, 0001493152-25-021894 |
| Operating Margin | 9.12% | Operating Income / Revenue | OK | 0001493152-26-037176, 0001493152-25-021894 |
| ROIC | 15.83% | NOPAT / Average Invested Capital | OK | 0001493152-26-037176, 0001493152-25-021894 |
| Net Debt / CFO | n/a | Net Debt / CFO | NOT_MEANINGFUL | 0001493152-26-037176 |
| Interest Coverage | 1.37x | Operating Income / abs(Interest Expense) | OK | derived |
| Current Ratio | 2.58x | Current Assets / Current Liabilities | OK | derived |
| Cash / Debt | 0.33x | (Cash + Short-term Investments) / Total Debt | OK | 0001493152-26-037176 |